Fmoc and Boc are the two dominant protection strategies in solid-phase synthesis, and the choice affects cleavage conditions, side-reaction profile, and available equipment.
Key Takeaways
- Fmoc protects the alpha-amine and is removed by base, usually piperidine, while the side-chain protecting groups are acid-labile and removed at the end.
- Boc chemistry can give better results for aggregation-prone sequences and for some long targets, because the repeated acid treatment keeps the chain protonated and reduces hydrogen-bonded aggregation.
- Default to Fmoc unless the sequence is known to be difficult or the target contains motifs incompatible with base treatment.
How they differ
Fmoc protects the alpha-amine and is removed by base, usually piperidine, while the side-chain protecting groups are acid-labile and removed at the end. Boc uses acid-labile temporary protection removed by TFA at each cycle, with side-chain groups removed by strong acid at the end.
Why Fmoc dominates
Fmoc chemistry avoids repeated exposure to strong acid and requires no hydrofluoric acid for final cleavage, so it runs on standard equipment. For most laboratories this operational simplicity outweighs its disadvantages.
For related mechanism work, see native chemical ligation.
Where Boc still wins
Boc chemistry can give better results for aggregation-prone sequences and for some long targets, because the repeated acid treatment keeps the chain protonated and reduces hydrogen-bonded aggregation. It requires HF-resistant apparatus and stricter safety controls.
Side-reaction profiles differ
Fmoc chemistry is associated with aspartimide formation and with piperidine-related adducts, while Boc chemistry carries risks from repeated acid exposure such as tert-butylation. Knowing which profile applies helps interpret an unexpected impurity.
Practical selection
Default to Fmoc unless the sequence is known to be difficult or the target contains motifs incompatible with base treatment. Discuss the choice with the synthesis provider rather than accepting a default.
Experimental Conditions and Practical Setup
Fmoc synthesis removes the temporary group with base at each cycle and performs a single acid cleavage at the end, which is why it runs on standard equipment. Boc synthesis removes the temporary group with acid at each cycle and requires a strong acid cleavage step, which demands compatible apparatus and stricter safety controls.
Side reactions associated with each strategy
| Strategy | Characteristic side reaction | Prevention |
|---|---|---|
| Fmoc | Aspartimide formation at Asp-Gly or Asp-Ser | Additive or backbone protection |
| Fmoc | Incomplete Fmoc removal on hindered residues | Extended or repeated deprotection |
| Boc | tert-Butylation from repeated acid exposure | Appropriate scavengers |
| Boc | Acid-catalysed backbone damage over many cycles | Optimised cleavage conditions |
Practical Notes for the Bench
- Default to Fmoc unless the sequence is known to be difficult.
- Consider Boc for aggregation-prone sequences if HF capability is available.
- Interpret unexpected impurities against the strategy’s known side reactions.
Frequently Asked Questions
Which strategy is more common?
Fmoc, because it avoids repeated strong-acid exposure and runs on standard synthesis equipment.
When is Boc preferable?
For aggregation-prone or certain long sequences where repeated acid treatment keeps the chain protonated and reduces on-resin aggregation.
What is aspartimide formation?
A base-catalysed side reaction associated with Fmoc chemistry that affects aspartate-containing sequences and produces a characteristic impurity.
Which strategy should I assume by default?
Fmoc, because it avoids repeated strong-acid exposure and runs on standard synthesisers. Boc is considered when a sequence is known to be aggregation-prone and the laboratory has the required capability.
Related Reading
- native chemical ligation
- peptide synthesis scale-up
- preparative HPLC peptide purification
- insulin analogue design
- melanocortin peptides
References & Further Reading
- Noki S et al. Safety-Catch Linkers for Solid-Phase Peptide Synthesis. Molecules. 2024. PubMed 38611709
- Schmutzler S et al. Solid-phase synthesis of D-fructose-derived Heyns peptides utilizing N(α)-Fmoc-Lysin[N(ε)-(2-deoxy-D-glucos-2-yl),N(ε)-Boc]-OH as building block. Amino Acids. 2021. PubMed 33934222
- Mende F et al. 9-Fluorenylmethoxycarbonyl-based solid-phase synthesis of peptide α-thioesters. Angew Chem Int Ed Engl. 2011. PubMed 21290490
- Peptide literature search on PubMed
- Full-text archive at PubMed Central
- FDA guidance documents on peptide drug products
Content here is written for researchers handling peptide reagents. It does not constitute medical guidance, dosing advice, or an endorsement of any supplier.
Reviewed by Dr. Elena Marchetti, Peptide Chemistry & Analytical Characterization.